Mondaq Australia: Intellectual Property > Patent
Norton Rose Fulbright Australia
With the rise of digital technologies and mining of big data, CIIs are increasingly utilised in a range of industries.
Shelston IP
Article records an interview with elite athlete & patent attorney about how innovation has played a part in sport & much more.
Shelston IP
This article emphasises the importance of retaining and revising, not abolishing, Australia's Innovation Patent System.
Spruson & Ferguson
These APO patent decisions provide guidance on the requirements and potential pitfalls when seeking an extension of term.
McCullough Robertson
Once this bill becomes law, IP owners will need to ensure their licences and assignments do not breach competition law.
Spruson & Ferguson
This change opens up technology imports to negotiation without mandatory restrictions which protected Chinese entities.
Davies Collison Cave
Since 2010 a series of decisions at the Patent Office and in the Courts has made life more difficult for applicants seeking protection for computer-implemented inventions in Australia.
Shelston IP
Infringement of a Swiss-style claim does require the pharmaceutical patentee to establish the manufacturer's intention.
Madderns Patent & Trade Mark Attorneys
The rules about the patentability in Europe of plants or plant products (obtained by a biological process) keep changing.
McCullough Robertson
Once this Bill becomes law, IP owners need to make sure their licences and assignments do not breach competition law.
Norton Rose Fulbright Australia
The article covers recent investigations, actions, outcomes and future trends in competition law in this industry sector.
Surry Partners
Article highlights that brand management has never been more important.
Corrs Chambers Westgarth
Further developments in the patent infringement proceedings between Motorola and Hytera are discussed here.
Shelston IP
This article considers whether a patent's novelty assessment is likely to be significantly different under the new Act.
AJ Park
Rokt appealed the decision, challenging the refusal of the application.
Dentons
A recent Federal Court decision has confirmed the Australian approach to the infringement of Swiss-style patent claims. The decision serves as a useful reminder of:
Shelston IP
This article includes some ideas to effectively manage the prosecution of New Zealand patent applications.
Shelston IP
The article discusses the history of medicinal cannabis, the Australian market and the types of IP that can be utilised.
Shelston IP
An Australian court could consider this decision, despite the Lords being split on the relevant test for plausibility.
Shelston IP
Article advocates for keeping the innovation patent and includes a link to a video advocating the same.
Most Popular Recent Articles
Shelston IP
Article records an interview with elite athlete & patent attorney about how innovation has played a part in sport & much more.
Norton Rose Fulbright Australia
With the rise of digital technologies and mining of big data, CIIs are increasingly utilised in a range of industries.
McCullough Robertson
Once this Bill becomes law, IP owners need to make sure their licences and assignments do not breach competition law.
Shelston IP
This article emphasises the importance of retaining and revising, not abolishing, Australia's Innovation Patent System.
McCullough Robertson
Once this bill becomes law, IP owners will need to ensure their licences and assignments do not breach competition law.
Davies Collison Cave
Since 2010 a series of decisions at the Patent Office and in the Courts has made life more difficult for applicants seeking protection for computer-implemented inventions in Australia.
Spruson & Ferguson
These APO patent decisions provide guidance on the requirements and potential pitfalls when seeking an extension of term.
Davies Collison Cave
In Encompass Corporation Pty Ltd v InfoTrack Pty Ltd [2018] FCA 421, Justice Perram of the Federal Court of Australia found two innovation patents to be invalid for not involving a manner of manufacture...
Jones Day
The Situation: Pfizer, a pharmaceutical manufacturer, brought an application for preliminary discovery of certain confidential documents belonging to Samsung Bioepis ("SB") ...
Shelston IP
Infringement of a Swiss-style claim does require the pharmaceutical patentee to establish the manufacturer's intention.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter